Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Posted on Jan 12, 2017
EDEN PRAIRIE, Minn., Jan. 12, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. today announced a 1-for-30 reverse split of its common stock, effective at 5:00 pm Eastern time today. Beginning tomorrow, January 13, 2017, the Company's common stock will trade on The Nasdaq Capital Market on a split adj...

Read More

Posted on Dec 21, 2016
EDEN PRAIRIE, Minn., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) ("Sunshine Heart" or the "Company") today urged stockholders of record at the close of business on December 2, 2016 to vote FOR all of the board proposals at the upcoming special meeting of stockholders, to be...

Read More

Posted on Dec 9, 2016
EDEN PRAIRIE, Minn., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH), today announced that on December 7, 2016, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved three equity awards under Sunshine Heart's New-Hir...

Read More

Events & Presentations

Posted on Nov 8, 2016 at 9:00 AM ET
Posted on Aug 24, 2016 at 11:45 AM CT
Posted on Aug 9, 2016 at 9:00 AM ET